GLAXF GSK plc

NEUTRAL Impact: 5/10 6-K
Horizon immediate Filed Apr 14, 2026 Processed 2mo ago SEC 0001654954-26-003463
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GLAXF ▼ -12.89% at T+20d
NEUTRAL call ✗ call lost -12.89% · α vs SPY -19.19% · entry $29.24 → $25.47
Next anchor: T+60d in 26d
Currently $26.63 · -8.93% from $29.24 entry
Entry anchored
Apr 14, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.78%
$29.24
settled 8w ago
T+5d
+0.89%
call +0.89% · α -0.50%
$29.50
settled 8w ago
T+20d
-12.89%
call -12.89% · α -19.19%
$25.47
settled 5w ago
T+60d
call — · α —
in 26d

Price Chart

Loading chart...

Executive Summary

GSK plc purchased 325,000 of its ordinary shares on April 13, 2026, at a volume-weighted average price of 2,169.64 GBp, as part of its ongoing buyback program. Since February 17, 2026, the company has acquired 18,546,521 shares.

Actionable Insight

This routine share buyback is unlikely to significantly impact the stock price. Traders should monitor the company's overall capital allocation strategy and future buyback activity for longer-term implications.

Key Facts

  • GSK purchased 325,000 ordinary shares on April 13, 2026.
  • The volume-weighted average price paid was 2,169.64 GBp per share.
  • This transaction is part of an existing buyback program initiated on February 17, 2026.
  • Since the program's inception, GSK has acquired 18,546,521 shares.
  • The purchased shares will be held as treasury shares.

Financial Impact

The transaction represents a purchase of approximately $7.0 million (based on 325,000 shares at ~$21.70 per share).

dilutiontreasury shares

Risk Factors

  • The buyback program could be suspended or modified in the future.
  • Market conditions could affect the execution price of future buybacks.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003463
Document: 0001654954-26-003463-index-headers.html0001654954-26-003463
Document: 0001654954-26-003463-index.html0001654954-26-003463
Document: 0001654954-26-003463.txt0001654954-26-003463
51 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 10, 2026
2d ago
6-K
NEUTRAL ★ 1/10
$23.54 awaiting T+5awaiting T+5$26.63 (+13.13%)
Jun 9, 2026
3d ago
6-K
NEUTRAL ★ 1/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 9, 2026
4d ago
6-K
BULLISH ★ 7/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
May 28, 2026
16d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.63 (+8.34%)
May 27, 2026
16d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.63 (+4.15%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 22, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.63 (+2.42%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (49h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access